Glaucoma in today's age

The current market has stagnated, with little innovation for several decades to treat increased pressure in the eye. Doctor's are screaming for new technology that can support their efforts in treating Glaucoma more efficiently.

Eye Trial Frame

The Etiology of Primary Open-Angle Glaucoma (POAG)

  • POAG is a chronic, degenerative optic neuropathy

  • Elevated intraocular pressure (IOP) is the primary treatable risk factor

  • Elevated IOP alters perfusion at the ganglion cells, nerve fiber layer & optic nerve

  • The neuroretinal rim of the optic nerve becomes progressively thinner enlarging the optic nerve cup

  • Optic nerve cupping is associated with loss of retinal ganglion cells (RGCs), glia, and supporting vasculature

  • POAG is characterized by progressive vision loss due to both the loss of RGCs and optic nerve damage

What is Glaucoma

The Problem is the Eye’s Meshwork, that increases pressure in the eye and rapidly requires treatment that can be costly

Eye Exam

Glaucoma Treatment is Cotly and Limiting

All current solutions can only be afforded by a subset of the population, and the treatments aren't as effective as ELT

Eye Exam
Eye Test

Treatment by Medication

Annual cost between $1,000-$2,000 per year

  • Daily medications (1-4x/day)

  • 70% do not adhere to medication

  • Annual cost estimate: $1,000-$2,000

Eye Lasers

Argon Laser Trabeculoplasty (ALT) & Selective Laser Trabeculoplasty (SLT)
Treatment cost between $1,000-$3,000

  • Effects diminish over time

  • Thermal damage to the eye

  • Requires monitoring & drugs

Invasive Survey: Trabeculectomy

On-time cost of $2,000 + on-going medication for $1,000+/year

  • Eye damage and post-operation variability

  • Lifestyle limitations are frequent

  • Regular medication is required